Why Wall Street can't get enough of this dividend king
AbbVie has an attractive 2.7% yield, a solid pharmaceutical business, and is clearly focused on its dividend.
AbbVie has an attractive 2.7% yield, a solid pharmaceutical business, and is clearly focused on its dividend.